Tectonic Therapeutic Adds Jessica Chutter with $165B Deal Experience to Board
Tectonic Therapeutic appointed Jessica Chutter to its Board effective June 8, 2026, drawing on her four decades in healthcare investment banking. Chutter advised on roughly $80 billion in capital raises and $85 billion in strategic deals, enhancing Tectonic's strategic financing capabilities.
1. Board Appointment of Jessica Chutter
Tectonic Therapeutic has appointed Jessica Chutter to its Board of Directors effective June 8, 2026. She joins the board as the company progresses its clinical-stage pipeline of therapeutic proteins and antibodies targeting GPCRs.
2. Investment Banking Track Record
Chutter brings over 40 years of global healthcare investment banking experience, most recently as Vice Chair of Healthcare Investment Banking and Chair of Biotechnology Investment Banking at Morgan Stanley. Over her career she advised on approximately $80 billion in capital raising transactions and $85 billion in strategic transactions.
3. Strategic Growth Implications
Her deep expertise in capital markets execution and strategic transactions is expected to bolster Tectonic’s fundraising initiatives and support corporate development as it advances multiple clinical programs and leverages its GEODe™ technology platform.